Pacific View Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pacific View Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,162	Closed	-$2.01M	–	23
2019 Q2	$2.01M	Sell	19,162 -12,194	-39%	-$1.31M	2.18%	14
2019 Q1	$3.93M	Buy	31,356 +6,286	+25%	+$781K	4.08%	10
2018 Q4	$2.83M	Buy	25,070 +16,380	+188%	+$2.54M	3.32%	14
2018 Q3	$1.86M	Buy	8,690 +7,403	+575%	+$1.86M	1.48%	18
2018 Q2	$360K	Buy	+1,287	New	+$226K	0.29%	76

Other funds holding MDGL

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pacific View Asset Management's MDGL Position: Q3 2019 in Review

Pacific View Asset Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2019, closing a stake of 19,162 shares — an estimated $2.01M sold.

Pacific View Asset Management first reported a position in MDGL in Q2 2018 and held it in 5 quarters. The position peaked at $3.93M in Q1 2019. 111 funds tracked by Wall St. Rank hold MDGL as of Q3 2019.

Pacific View Asset Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Pacific View Asset Management sold 19,162 Madrigal Pharmaceuticals shares in Q3 2019, an estimated $2.01M.
Pacific View Asset Management first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
Pacific View Asset Management's Madrigal Pharmaceuticals position peaked at $3.93M in Q1 2019.
111 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.